SCHEMBL21849243

SCHEMBL21849243

CC(C)(C)c1ccc(OCCC(C)(C)c2cccc(OCCF)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
MITF O75030 1/20 0.39
TP53 P04637 1/20 0.39
SOD1 P00441 1/20 0.39
CYP3A4 P08684 1/20 0.38
APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21849219 0.84 L3MBTL1 (0.56) L3MBTL1LMNAPOLBHTTSOD1
SCHEMBL16216287 0.81 KDM4E (0.54) LMNAPOLBSMN1; SMN2KDM4EALDH1A1
SCHEMBL13567551 0.81 KDM4E (0.54) LMNAPOLBSMN1; SMN2KDM4EALDH1A1
SCHEMBL18764220 0.77 L3MBTL1 (0.45) L3MBTL1LMNAPOLBHTTKDM4E
SCHEMBL19155927 0.76 L3MBTL1 (0.47) L3MBTL1LMNAPOLBHTTSOD1
SCHEMBL12384897 0.75 L3MBTL1 (0.56) L3MBTL1LMNAPOLBHTTSMN1; SMN2
SCHEMBL21325321 0.74 L3MBTL1 (0.40) L3MBTL1LMNAPOLBHTTSOD1
SCHEMBL25948414 0.74 CNR1 (0.39) L3MBTL1LMNAPOLBHTTSMN1; SMN2
SCHEMBL10458221 0.73 L3MBTL1 (0.60) L3MBTL1LMNAHTTKDM4EALDH1A1
SCHEMBL10705548 0.72 CHRNB2 (0.57) LMNAPOLBSMN1; SMN2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200102311-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102311-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP L3MBTL1 1131/4885LMNA 1845/4885POLB 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.